Terms: = Head and neck cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
19 results:
1. PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.
Kawasaki K; Noma K; Kato T; Ohara T; Tanabe S; Takeda Y; Matsumoto H; Nishimura S; Kunitomo T; Akai M; Kobayashi T; Nishiwaki N; Kashima H; Maeda N; Kikuchi S; Tazawa H; Shirakawa Y; Fujiwara T
Cancer Immunol Immunother; 2023 Nov; 72(11):3787-3802. PubMed ID: 37668710
[TBL] [Abstract] [Full Text] [Related]
2. Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival.
Bouaoud J; Foy JP; Tortereau A; Michon L; Lavergne V; Gadot N; Boyault S; Valantin J; De Souza G; Zrounba P; Bertolus C; Bendriss-Vermare N; Saintigny P
Oncoimmunology; 2021; 10(1):1944554. PubMed ID: 34239777
[TBL] [Abstract] [Full Text] [Related]
3. Immune microenvironment in Barrett's esophagus adjacent to esophageal adenocarcinoma: possible influence of adjacent mucosa on cancer development and progression.
Gokon Y; Fujishima F; Taniyama Y; Ishida H; Yamagata T; Sawai T; Uzuki M; Ichikawa H; Itakura Y; Takahashi K; Yajima N; Hagiwara M; Nishida A; Ozawa Y; Sakuma T; Kanba R; Sakamoto K; Zuguchi M; Saito M; Kamei T; Sasano H
Virchows Arch; 2020 Dec; 477(6):825-834. PubMed ID: 32533341
[TBL] [Abstract] [Full Text] [Related]
4. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-Infiltrating CD1a
Ni YH; Zhang XX; Lu ZY; Huang XF; Wang ZY; Yang Y; Dong YC; Jing Y; Song Y; Hou YY; Hua ZC; Hu QG
Pathol Oncol Res; 2020 Jul; 26(3):1687-1695. PubMed ID: 31606786
[TBL] [Abstract] [Full Text] [Related]
6. PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
Jiang F; Yu W; Zeng F; Cheng G; Xu J; Yang S; Shui Y; Wu D; Yu XF; Wei Q
BMC Cancer; 2019 May; 19(1):503. PubMed ID: 31138162
[TBL] [Abstract] [Full Text] [Related]
7. IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal cancer.
Kiyozumi Y; Baba Y; Okadome K; Yagi T; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Baba H
Ann Surg; 2019 Jun; 269(6):1101-1108. PubMed ID: 31082908
[TBL] [Abstract] [Full Text] [Related]
8. HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer.
Cioni B; Jordanova ES; Hooijberg E; van der Linden R; de Menezes RX; Tan K; Willems S; Elbers JBW; Broeks A; Bergman AM; Zuur CL; de Boer JP
Head Neck; 2019 Feb; 41(2):463-478. PubMed ID: 30549362
[TBL] [Abstract] [Full Text] [Related]
9. Programmed death-1 ligands and tumor infiltrating T lymphocytes in primary and lymph node metastasis of esophageal cancer patients.
Konno-Kumagai T; Fujishima F; Nakamura Y; Nakano T; Nagai T; Kamei T; Sasano H
Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30085020
[TBL] [Abstract] [Full Text] [Related]
10. CD45RA
Ihara F; Sakurai D; Horinaka A; Makita Y; Fujikawa A; Sakurai T; Yamasaki K; Kunii N; Motohashi S; Nakayama T; Okamoto Y
Cancer Immunol Immunother; 2017 Oct; 66(10):1275-1285. PubMed ID: 28551813
[TBL] [Abstract] [Full Text] [Related]
11. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
[TBL] [Abstract] [Full Text] [Related]
12. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
Oguejiofor K; Hall J; Slater C; Betts G; Hall G; Slevin N; Dovedi S; Stern PL; West CM
Br J Cancer; 2015 Sep; 113(6):886-93. PubMed ID: 26313665
[TBL] [Abstract] [Full Text] [Related]
13. CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated head and neck cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.
Jie HB; Schuler PJ; Lee SC; Srivastava RM; Argiris A; Ferrone S; Whiteside TL; Ferris RL
Cancer Res; 2015 Jun; 75(11):2200-10. PubMed ID: 25832655
[TBL] [Abstract] [Full Text] [Related]
14. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract] [Full Text] [Related]
15. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.
Balermpas P; Michel Y; Wagenblast J; Seitz O; Weiss C; Rödel F; Rödel C; Fokas E
Br J Cancer; 2014 Jan; 110(2):501-9. PubMed ID: 24129245
[TBL] [Abstract] [Full Text] [Related]
16. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.
Badoual C; Hans S; Merillon N; Van Ryswick C; Ravel P; Benhamouda N; Levionnois E; Nizard M; Si-Mohamed A; Besnier N; Gey A; Rotem-Yehudar R; Pere H; Tran T; Guerin CL; Chauvat A; Dransart E; Alanio C; Albert S; Barry B; Sandoval F; Quintin-Colonna F; Bruneval P; Fridman WH; Lemoine FM; Oudard S; Johannes L; Olive D; Brasnu D; Tartour E
Cancer Res; 2013 Jan; 73(1):128-38. PubMed ID: 23135914
[TBL] [Abstract] [Full Text] [Related]
17. Tumor infiltrating CD8+ and foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer.
Näsman A; Romanitan M; Nordfors C; Grün N; Johansson H; Hammarstedt L; Marklund L; Munck-Wikland E; Dalianis T; Ramqvist T
PLoS One; 2012; 7(6):e38711. PubMed ID: 22701698
[TBL] [Abstract] [Full Text] [Related]
18. clinical significance of tumor-infiltrating foxp3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Kim KH; Kim TM; Go H; Kim WY; Jeon YK; Lee SH; Kim DW; Khwarg SI; Kim CW; Heo DS
Cancer Sci; 2011 Nov; 102(11):1972-6. PubMed ID: 21812857
[TBL] [Abstract] [Full Text] [Related]
19. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.
Kono K; Kawaida H; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Fujii H
Cancer Immunol Immunother; 2006 Sep; 55(9):1064-71. PubMed ID: 16328385
[TBL] [Abstract] [Full Text] [Related]
